249 related articles for article (PubMed ID: 37556531)
61. Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
[TBL] [Abstract][Full Text] [Related]
62. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
63. Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation.
Yuan W; Wu T; Fu H; Dai C; Wu H; Liu N; Li X; Xu M; Zhang Z; Niu T; Han Z; Chai J; Zhou XJ; Gao S; Zhu B
Science; 2012 Aug; 337(6097):971-5. PubMed ID: 22923582
[TBL] [Abstract][Full Text] [Related]
64. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Bott M; Brevet M; Taylor BS; Shimizu S; Ito T; Wang L; Creaney J; Lake RA; Zakowski MF; Reva B; Sander C; Delsite R; Powell S; Zhou Q; Shen R; Olshen A; Rusch V; Ladanyi M
Nat Genet; 2011 Jun; 43(7):668-72. PubMed ID: 21642991
[TBL] [Abstract][Full Text] [Related]
65. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
[TBL] [Abstract][Full Text] [Related]
66. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1.
He M; Chaurushiya MS; Webster JD; Kummerfeld S; Reja R; Chaudhuri S; Chen YJ; Modrusan Z; Haley B; Dugger DL; Eastham-Anderson J; Lau S; Dey A; Caothien R; Roose-Girma M; Newton K; Dixit VM
Science; 2019 Apr; 364(6437):283-285. PubMed ID: 31000662
[TBL] [Abstract][Full Text] [Related]
67. Loss of the tumor suppressor BAP1 causes myeloid transformation.
Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
[TBL] [Abstract][Full Text] [Related]
68. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119.
Köhnke T; Nuno KA; Alder CC; Gars EJ; Phan P; Fan AC; Majeti R
Blood Cancer Discov; 2024 May; 5(3):202-223. PubMed ID: 38359087
[TBL] [Abstract][Full Text] [Related]
69. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
70. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.
Valletta S; Dolatshad H; Bartenstein M; Yip BH; Bello E; Gordon S; Yu Y; Shaw J; Roy S; Scifo L; Schuh A; Pellagatti A; Fulga TA; Verma A; Boultwood J
Oncotarget; 2015 Dec; 6(42):44061-71. PubMed ID: 26623729
[TBL] [Abstract][Full Text] [Related]
71. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
[TBL] [Abstract][Full Text] [Related]
72. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function.
Hebert L; Bellanger D; Guillas C; Campagne A; Dingli F; Loew D; Fievet A; Jacquemin V; Popova T; Jean D; Mechta-Grigoriou F; Margueron R; Stern MH
Oncotarget; 2017 Sep; 8(42):72513-72527. PubMed ID: 29069806
[TBL] [Abstract][Full Text] [Related]
73. The histone H2A deubiquitinase Usp16 regulates hematopoiesis and hematopoietic stem cell function.
Gu Y; Jones AE; Yang W; Liu S; Dai Q; Liu Y; Swindle CS; Zhou D; Zhang Z; Ryan TM; Townes TM; Klug CA; Chen D; Wang H
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E51-60. PubMed ID: 26699484
[TBL] [Abstract][Full Text] [Related]
74. An Adversarial DNA N
Kweon SM; Chen Y; Moon E; Kvederaviciutė K; Klimasauskas S; Feldman DE
Mol Cell; 2019 Jun; 74(6):1138-1147.e6. PubMed ID: 30982744
[TBL] [Abstract][Full Text] [Related]
75. Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.
Lai HL; Wang QT
PLoS One; 2013; 8(9):e73983. PubMed ID: 24040135
[TBL] [Abstract][Full Text] [Related]
76. Cancer-associated DNA Hypermethylation of Polycomb Targets Requires DNMT3A Dual Recognition of Histone H2AK119 Ubiquitination and the Nucleosome Acidic Patch.
Gretarsson KH; Abini-Agbomson S; Gloor SL; Weinberg DN; McCuiston JL; Kumary VUS; Hickman AR; Sahu V; Lee R; Xu X; Lipieta N; Flashner S; Adeleke OA; Popova IK; Taylor HF; Noll K; Windham CL; Maryanski DN; Venters BJ; Nakagawa H; Keogh MC; Armache KJ; Lu C
bioRxiv; 2024 Mar; ():. PubMed ID: 38562823
[TBL] [Abstract][Full Text] [Related]
77. Role of the polycomb protein EED in the propagation of repressive histone marks.
Margueron R; Justin N; Ohno K; Sharpe ML; Son J; Drury WJ; Voigt P; Martin SR; Taylor WR; De Marco V; Pirrotta V; Reinberg D; Gamblin SJ
Nature; 2009 Oct; 461(7265):762-7. PubMed ID: 19767730
[TBL] [Abstract][Full Text] [Related]
78. Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma.
Pandey GK; Landman N; Neikes HK; Hulsman D; Lieftink C; Beijersbergen R; Kolluri KK; Janes SM; Vermeulen M; Badhai J; van Lohuizen M
Cell Rep Med; 2023 Feb; 4(2):100915. PubMed ID: 36657447
[TBL] [Abstract][Full Text] [Related]
79. UbE2E1/UBCH6 Is a Critical
Wheaton K; Sarkari F; Stanly Johns B; Davarinejad H; Egorova O; Kaustov L; Raught B; Saridakis V; Sheng Y
J Biol Chem; 2017 Feb; 292(7):2893-2902. PubMed ID: 28073915
[TBL] [Abstract][Full Text] [Related]
80. BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
Liu X; Kumar M; Yang L; Molkentine DP; Valdecanas D; Yu S; Meyn RE; Heymach JV; Skinner HD
Clin Cancer Res; 2018 Feb; 24(3):600-607. PubMed ID: 29113987
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
